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DObjective: To determine the effect of reintervention for coarctation after stage 1 reconstruction for hypoplastic
left heart syndrome and variants on survival, suitability for Fontan, and morbidity at Fontan.
Methods:A retrospective review of echocardiograms, catheterizations, hospital records of patients who underwent
stage 1 reconstruction from January 2002 to May 2005, with a cross-sectional analysis of hospital survivors, was
performed. Kaplan–Meier curves were derived for patients alive more than 30 days after stage 1 reconstruction.
Results: A total of 176 patients underwent stage 1 reconstruction. Forty-three patients (23%) underwent balloon
angioplasty (n ¼ 43) or surgical intervention (n ¼ 4) for re-coarctation. Median time to intervention was 123
(1–316) days. Seven of 43 patients (16%) underwent more than 1 balloon angioplasty. Thirty-nine patients un-
derwent intervention before stage 2 reconstruction, and 4 patients had intervention between stage 2 reconstruction
and Fontan. Kaplan–Meier curves showed no difference in freedom from death or transplant between patients
who did and did not undergo intervention for re-coarctation. Fontan completion was performed in 107 patients.
By echocardiogram, the prevalence of moderate to severe ventricular dysfunction between groups was similar at
Fontan; however, significant atrioventricular valve regurgitation was more common in patients who required in-
tervention (28/33 vs 40/65, P¼ .02). Overall Fontan mortality was 2% and not different between groups. Length
of stay was not different between patients with and without re-coarctation.
Conclusions: Reintervention for coarctation after stage 1 reconstruction is common. Hemodynamic differences
between groups did not affect Fontan completion, mortality, or hospital length of stay. Follow-up is necessary to
determine the impact of re-coarctation on longer-term mortality and morbidity. (J Thorac Cardiovasc Surg
2010;140:545-9)Multiple factors have resulted in improved survival among in-
fants born with functional single-ventricle lesions. These fac-
tors include surgical modifications, improved surgical
technique, modifications to preoperative and postoperative
care, and a better understanding of the cardiac physiology of
patients with single ventricles undergoing surgical pallia-
tion.1-6 Attention has now shifted toward understanding
variables that may result in mortality or less favorable
hemodynamic and functional status as the patients move
through staged palliation. One such variable is the
occurrence of recurrent arch obstruction. The reported
incidence of recurrent arch obstruction after stage 1
reconstruction (S1R) ranges from 9% to 37%.7-14 Recurrent
arch obstruction has been observed to result in worse
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The Journal of Thoracic and Caheart syndrome (HLHS), with improvement toward previous
baseline with timely intervention of the recurrent
obstruction.15 In addition, a single postmortem study has dem-
onstrated that recurrent arch obstruction was the primary cause
of death in 14% of patients evaluated by autopsy after
in-hospital death post-S1R.16 The aim of this study was to
evaluate the consequences of re-coarctation after S1R or stage
2 reconstruction (S2R) on Fontan completion for HLHS and
other single ventricle variants.
MATERIALS AND METHODS
Study Patients and Design
This study was a cross-sectional case series including all patients who un-
derwent S1R for HLHS or variants at The Children’s Hospital of Philadelphia
between January 1, 2002, and May 1, 2005 (n¼ 176), with particular attention
paid to patients alive more than 30 days after S1R (n¼ 156). Patient data were
collected through April 16, 2009. This was a consent-waived study approved
by The Children’s Hospital of Philadelphia Institutional Review Board. Sour-
ces of information included the hospital medical records, the cardiac center
and cardiac intensive care databases, and the records and reports provided
by referring cardiologists. Recurrent arch obstruction was defined as those
patients who underwent reintervention (surgical or balloon angioplasty) of
the reconstructed aortic arch. Balloon angioplasties performed both at The
Children’s Hospital of Philadelphia and the referring institutions were
included for analysis. There were no prospective criteria established for the
diagnosis or treatment of recurrent arch obstruction. Blood pressure gradient
was not used as a criterion for intervention because of the difficulty in accurate
measurement, the possibility for small gradients in the presence of poor car-
diac output, and the lack of a uniform number for intervention from institutionrdiovascular Surgery c Volume 140, Number 3 545
Abbreviations and Acronyms
HLHS ¼ hypoplastic left heart syndrome
S1R ¼ stage 1 reconstruction
S2R ¼ stage 2 reconstruction
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Dto institution. The decision for intervention was made by the attending cardi-
ologist and cardiac surgeon on the basis of echocardiographic evidence of
recurrent arch obstruction: decreased ventricular systolic function, increased
atrioventricular valve regurgitation or abnormal abdominal Doppler flow
pattern, or catheterization data including pullback gradient and angiographic
appearance.
We reviewed the most recent echocardiographic report before arch inter-
vention for the patients with documented arch obstruction for assessment of
ventricular systolic function and atrioventricular valve regurgitation. Post-
intervention echocardiographic data were recorded when available. These
data were also recorded from echocardiographic reports before Fontan com-
pletion for all patients.
Hemodynamic data obtained at cardiac catheterization with conscious
sedation or a general anesthetic at the time of arch intervention included
pre- and post-balloon angioplasty gradients, ventricular end-diastolic pres-
sure, common atrial pressure, and mean pulmonary artery pressure. These
data were recorded at the time of pre-Fontan catheterization for patients
who underwent repeat catheterization before Fontan completion. For
patients without catheterization, upper- and lower-extremity blood pressure
measurements were documented before Fontan completion.
Statistical Analysis
Analyses were performed for all patients who underwent S1R and for
those who survived past 30 days of life.
Descriptive Statistics
Continuous variables are presented as mean  standard deviation for
normally distributed data and median (range) otherwise. Categoric data
and ordinal data are presented as n (%).
Patients With Recurrent Arch Obstruction
Depending on the distribution, a paired analysis using the Wilcoxon
signed-rank test or Student t test was performed to compare hemodynamic
data before and after balloon dilation angioplasty. The time to re-coarctation
was studied using the Kaplan–Meier method to estimate re-coarctation rates
at different time points and survival curves. Potential risk factors for recurrent
arch obstruction were assessed using Cox proportional hazards regression.
Comparisons Between Patients With and Without
Arch Obstruction at the Time of Fontan
The Student t test or Wilcoxon rank-sum test was used to compare hemo-
dynamic and physiologic data between patient groups depending on the
distribution. For comparisons using binary or categoric data, a chi-square
test or Fisher’s exact test was used. The Wilcoxon rank-sum test was
used to compare ordinal data, such as the degree of atrioventricular valve
regurgitation, between groups.Survival Analysis
The Kaplan–Meier method was used to estimate survival to death or
transplant at different time points. Survival differences between those pa-
tients with and without arch obstruction were compared using the log-
rank test. The statistical analysis was performed using STATA 9.0 (Stata
Corp, College Station, Tex).546 The Journal of Thoracic and Cardiovascular SurgRESULTS
Between January 1, 2002, and May 1, 2005, 176 patients
underwent S1R for HLHS or single ventricle variants at The
Children’s Hospital of Philadelphia. Patients dying after sur-
gery but before 30 days of life (n ¼ 20) were excluded from
the secondary analysis because they did not have the potential
to become eligible for Fontan completion. Of the 156 patients
included, 94 (60%) were male and 62 (40%) were female.
Other patient characteristics, including cardiac anatomy,
weight, and age at the time of S1R, are summarized in Table 1.
The S1R was performed by 4 surgeons, and all procedures
used deep hypothermic circulatory arrest. The standard ap-
proach, independent of the type of pulmonary shunt used, in-
cluded an atrial septectomy and division of the main
pulmonary artery with side-to-side anastomosis to the di-
minutive ascending aorta without aortic transection. Rou-
tinely, the aorta was incised and the incision was carried
across the arch of the aorta beyond the ductal insertion site
onto the descending thoracic aorta. Ductal tissue was
excised, and the proximal ascending aorta was tacked side
to side to the pulmonary artery. The entire arch of the aorta
was then augmented with a patch of pulmonary homograft.
Co-artectomy was not routinely performed. Other patient
and surgical characteristics have been summarized.17-19
Patients With Recurrent Arch Obstruction
The arch obstruction recurrence rate was 23% (43/176)
for the original patient cohort. Recurrent arch obstruction
for patients alive at more than 30 days of life was 26%
(42/156). Forty-three patients underwent balloon angio-
plasty or surgical intervention (n¼ 4). Three of the 4 patients
requiring surgical intervention had supraaortic obstruction
that was intervened upon at the time of the S2R. Seven pa-
tients (16%) required more than 1 balloon angioplasty.
Thirty-nine patients (91%) had balloon angioplasty only be-
tween S1R and S2R, and 4 patients required balloon angio-
plasty for recurrent arch obstruction both before S2R and
Fontan. The median time to surgical or catheter intervention
was 123 (1–316) days.
The cardiac catheterization data at the time of intervention
are as follows for those patients with recurrent arch obstruc-
tion. The gradient by pull-back measurement before interven-
tion was 28.5 (2–53) mm Hg. After balloon angioplasty, the
gradient decreased to 1 (0–20) mm Hg. The end-diastolic
pressure in the ventricle at the time of arch obstruction was
10 (4–15) mm Hg, with a filling pressure of 7 (3–15) mm
Hg and mean pulmonary artery pressure of 12 (6–26) mm Hg.
Comparison of PatientsWith andWithout Recurrent
Arch Obstruction
Among preoperative risk factors, the presence of signifi-
cant noncardiac congenital anomalies was associated with
recurrent arch obstruction (P ¼ .002). Other factors, such
as birth weight less than 2.5 kg, preoperative shock orery c September 2010
TABLE 1. Patient characteristics at stage 1 reconstruction (n ¼ 156)
Anatomic subtype
HLHS 106 (68%)
DORV or VSD with MA/MS 20 (13%)
Single LV 16 (10%)
UAVC 10 (6.5%)
Other 4 (2.5%)
Gender
Male 94 (60%)
Female 62 (40%)
Weight (kg) 3.1 (1.4–4.5)
Age at surgery (d) 3 (0–29)
HLHS, Hypoplastic left heart syndrome; DORV, double outlet right ventricle; VSD,
ventricular septal defect; MA/MS, mitral atresia/mitral stenosis; LV, left ventricle;
UAVC, unbalance atrioventricular canal.
FIGURE 1. Kaplan–Meier: Freedom from death or transplant in patients
with and without recurrent arch obstruction requiring reintervention before
Fontan completion.
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Dpresence of a genetic syndrome, or diagnosis of aortic atre-
sia, were not associated with recurrent arch obstruction.
Survival. Of the 156 patients who survived more than 30
days of life, an additional 10 died before hospital discharge,
5 have undergone heart transplantation, 25 have been lost to
interstage death, 1 has undergone conversion to a 2-ventricle
palliation, and 8 await further palliative surgery. A total of
107 patients have undergone Fontan completion. Seven
patients with previous balloon angioplasty for recurrent
arch obstruction have died: 6 before Fontan completion
and 1 after Fontan completion. Recurrent arch obstruction
after balloon angioplasty was not documented by echocar-
diogram for any of the 7 deaths. Incidence of interstage death
was not different between the 2 groups (arch obstruction
7/43 [16%] vs others 25/156 [16%], P ¼ .842).
Patient and operative characteristics have been described
for those who previously underwent Fontan completion.18
Patient weight at time of Fontan completion was not differ-
ent between the 2 groups (arch obstruction 13  2 kg vs
others 13  1.7 kg, P ¼ .337). There was no difference in
patient age at time of Fontan completion between groups
(arch obstruction 33.6 months [19.4–44.7] vs others 34.8
months [18.3–53.8], P ¼ .675).
Cardiac catheterization findings at time of Fontan.
Eighty-one of the 107 patients with Fontan completion un-
derwent cardiac catheterization before surgery. Thirty of
the patients (81%) with previous recurrent arch obstruction
underwent repeat cardiac catheterization before Fontan com-
pletion. Common atrial pressure was significantly higher at
pre-Fontan catheterization for those patients with previous
arch obstruction (8 [5–12] mm Hg vs others 6 [3–15] mm
Hg; P¼ .035). Mean pulmonary artery pressure was not dif-
ferent between the 2 groups, with a mean pulmonary artery
pressure of 12 (9–26) mm Hg in patients with previous
arch obstruction versus 11 (8–24) mm Hg in patients without
obstruction (P ¼ .328). Pull-back gradient across the aortic
arch or upper- and lower-extremity blood pressure measure-
ment were available for 83 of the 107 patients who underwent
Fontan completion. Notably, there was no difference in resid-The Journal of Thoracic and Caual gradient from ascending to descending aorta by these
measurement techniques between the 2 groups (arch obstruc-
tion 0 [0–10] mm Hg vs no arch obstruction 0 [0–6] mm Hg;
P ¼ 0.355).
Echocardiogram findings at time of Fontan. Echocardio-
graphic data were available for 98 patients before Fontan.
There was no difference in the prevalence of qualitative
moderate or severe ventricular systolic dysfunction between
those with and without recurrent arch obstruction (2/33
[6%] vs 4/65 [6%], P ¼ .86). Qualitatively moderate or
severe atrioventricular valve regurgitation was more com-
mon in patients with recurrent arch obstruction than in those
without (28/33 [85%] vs 40/65 [62%], P ¼ .039).
Hospital length of stay, mortality, and late outcomes
after Fontan. Hospital length of stay at the time of the Fon-
tan completion was not different between those patients with
recurrent arch obstruction (8.5 [2–73] days) and those with-
out (8 [3–37] days, P ¼ .86). Overall mortality after Fontan
was 2%. One patient with previous arch obstruction died of
sepsis during the Fontan hospitalization. One patient without
recurrent arch obstruction had a sudden cardiac arrest requir-
ing extracorporeal membrane oxygenation cannulation with
subsequent withdrawal of support secondary to embolic
complications of heparin-induced thrombocytopenia.
The median duration of follow-up was 58 months (range,
1–87 months). There have been no deaths or transplants in
either group after Fontan completion and hospital discharge
through the current follow-up. By Kaplan–Meier analysis,
recurrent arch obstruction did not influence survival or free-
dom from transplant at 5 years (arch obstruction 79%, 95%
confidence limit, 63%–89%, vs others 59%, 95% confi-
dence limit, 59%–75%; P ¼ .24; Figure 1).
DISCUSSION
This analysis of patients undergoing S1R between January
1, 2002, and May 1, 2005, demonstrates several significantrdiovascular Surgery c Volume 140, Number 3 547
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defined by need for intervention after S1R. (2) Patients
with obstruction had significantly higher common filling
pressures and decreased systolic ventricular function before
intervention. (3) Balloon angioplasty was successful in
relieving recurrent arch obstruction. (4) Arch obstruction
before S2R did not affect interstage sudden death. (5) Com-
mon atrial pressure and increased atrioventricular valve re-
gurgitation remained at time of Fontan in the absence of
continued arch obstruction. (6) Recurrent arch obstruction
did not affect Fontan morbidity, mortality, or intermediate
survival.
Recurrent arch obstruction after S1R for HLHS and other
single-ventricle variants has been observed to range from
9% to 37%.7-14 In this series we found an incidence of
23%, with the need for multiple balloon angioplasties also
high at 16%. The majority of interventions for recurrent
arch obstruction were between S1R and S2R, a vulnerable
period for interstage death in this patient population.
Despite improved overall survival, it has been suggested
that interstage death may be casually related to the
occurrence of re-coarctation.9 However, although there
was not a systematic approach to evaluation for recurrent
arch obstruction and limited autopsy data, data from this
analysis and our previous evaluations of risk factors for inter-
stage death do not support this association in the current
era.19
As has been previously documented in several studies,
significant, qualitative ventricular systolic dysfunction was
common in those patients with the increased afterload of
arch obstruction.13,15 In addition, the increased afterload
may have contributed to the higher incidence of moderate
to severe atrioventricular valve regurgitation at the time of
re-coarctation. Notably, even in the absence of continued
arch obstruction at the time of the Fontan completion, com-
mon atrial filling pressures and significant atrioventricular
valve regurgitation remained. These findings were in the ab-
sence of ongoing increased afterload from arch obstruction
and may be related to diastolic dysfunction, ventricular hy-
pertrophy, or other changes that occurred at the time of the
recurrent arch obstruction.
Several studies of recurrent arch obstruction have shown that
mid- and long-term survivals are affected by re-coarctation
without a specific causality.13,20 In this series, recurrent arch
obstruction did not have an impact on mortality or need for
transplantation at a median of 58 months. The primary
objective of this study was to investigate the relationship of
recurrent arch obstruction and suitability for Fontan
completion. We did not find that recurrent arch obstruction,
even in patients who required both balloon angioplasty and
surgical revision or multiple balloon dilations, had a negative
impact on the ability to be palliated through Fontan
completion. Its effect on long-term ventricular function was
not evaluated in this study but remains of great concern.548 The Journal of Thoracic and Cardiovascular SurgStudy Limitations
This study is limited by its retrospective nature and the
biases inherent in this type of study design. A nonrandom-
ized patient population was studied, with possible uneven
distribution of unrecognized preoperative risk factors be-
tween groups. The study population is also a preselected
group by virtue of the fact that they had to survive the first
30 days of life. Patients who died before this time with recur-
rent arch obstruction were not included. Assessment and
intervention were not by protocol and may have changed
over the course of the study duration. Along these lines,
there is an inherent bias in patient selection because those
with decreased ventricular systolic function or significant
atrioventricular valve regurgitation, in addition to increased
filling pressures, were more commonly found in the group
that underwent intervention, because we used these hemody-
namic indicators as surrogate markers of recurrent arch ob-
struction. This study might not be powered to evaluate
small differences between comparison groups.CONCLUSIONS
Recurrent arch obstruction after S1R is a common and
significant problem that can result in worse qualitative
systolic ventricular function and atrioventricular valve
regurgitation. However, with relief and continued monitor-
ing for evidence of re-coarctation by clinical examination,
blood pressure gradient changes, change in the degree of
ventricular systolic dysfunction, development of atrioven-
tricular valve regurgitation, 2-dimensional and Doppler
evidence of arch obstruction by echocardiogram, and sub-
sequent intervention for recurrent arch obstruction, re-
coarctation does not adversely affect suitability for Fontan
completion, need for transplantation, or death in our series.
Longer-term follow-up is warranted to evaluate for poten-
tial Fontan failure and increased late mortality in this
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